MERGERS AND ACQUISITIONSDrug Win for Depomed Could Be Hurdle for StarboardBy Scott StuartOct 4, 2016 3:49 PM EDT
MERGERS AND ACQUISITIONSApollo Education buyout feels sqeeze from ITT liquidationBy Scott StuartSep 23, 2016 10:04 AM EDT
MERGERS AND ACQUISITIONSInterOil pricing period likely underway as Exxon vote loomsBy Scott StuartSep 21, 2016 10:38 AM EDT
MERGERS AND ACQUISITIONSBayer's new bid seen as close to Monsanto's priceBy Scott StuartSep 7, 2016 11:01 AM EDT
MERGERS AND ACQUISITIONSDelaware expected to rule in favor of Energy Transfer on Williams mergerBy Scott StuartJun 22, 2016 4:21 PM EDT
MERGERS AND ACQUISITIONSISS recommends Williams shareholders back Energy Transfer mergerBy Scott StuartJun 15, 2016 5:47 PM EDT
INVESTINGValspar merger with Sherwin-Williams gets an extended antitrust review.By Scott StuartMay 12, 2016 1:08 PM EDT
INVESTINGCoca-Cola bottling approval in South Africa could bode well for SABMiller mergerBy Scott StuartMay 10, 2016 4:14 PM EDT
MERGERS AND ACQUISITIONSApollo Education may sell university if buyout failsBy Scott StuartApr 26, 2016 4:36 PM EDT
MERGERS AND ACQUISITIONSHow Treasury's Action Could Kill Pfizer-Allergan MergerBy Scott StuartApr 5, 2016 5:37 PM EDT
MERGERS AND ACQUISITIONSBASF Spoiler Bid for DuPont a Remote PossibilityBy Scott StuartMar 8, 2016 10:08 AM EST
MERGERS AND ACQUISITIONSLocal Opposition Continues to Delay Pepco-Exelon Merger By Scott StuartMar 3, 2016 8:42 AM EST
MERGERS AND ACQUISITIONSHealth Net, Centene merger faces California scrutinyBy Scott StuartFeb 18, 2016 8:51 AM EST
MERGERS AND ACQUISITIONSSanDisk-Western Digital merger fights through regulatory static By Scott StuartJan 27, 2016 9:15 AM EST
MERGERS AND ACQUISITIONSPossible FTC Deadlock Could Aid Staples-Office Depot MergerBy Scott StuartDec 1, 2015 8:36 AM EST
MERGERS AND ACQUISITIONSPfizer's Bid for Allergan May Be Too Good to Turn DownBy Scott StuartOct 29, 2015 5:56 PM EDT
MERGERS AND ACQUISITIONSWestern Digital, SanDisk Merger Hinges on Unisplendour's OKBy Scott StuartOct 22, 2015 9:13 AM EDT
MERGERS AND ACQUISITIONSDialog's $3.8 Billion Deal for Atmel Is a Long BetBy Scott StuartSep 24, 2015 9:04 AM EDT
MERGERS AND ACQUISITIONSMarket Doubts Staples-Office Depot Merger Will Actually HappenBy Scott StuartSep 1, 2015 8:36 AM EDT
MERGERS AND ACQUISITIONSHorizon and Depomed Sue Each Other Over Takeover TacticsBy Scott StuartAug 4, 2015 10:50 AM EDT
MERGERS AND ACQUISITIONSHorizon Raises Bid for Specialty Pharma Company DepomedBy Scott StuartJul 21, 2015 6:32 PM EDT
MERGERS AND ACQUISITIONSArbs Betting Another Buyer Jumps Into Towers Watson-Willis Group MergerBy Scott StuartJun 30, 2015 5:35 PM EDT
MERGERS AND ACQUISITIONSAbbott Backs Mylan and Its Strategy to Buy PerrigoBy Scott StuartJun 16, 2015 8:01 PM EDT
MERGERS AND ACQUISITIONSPartnerRe, Exor Takeover Battle Leads to Class WarfareBy Scott StuartJun 10, 2015 9:33 AM EDT
MERGERS AND ACQUISITIONSMylan Raises Its Offer for Generics Counterpart PerrigoBy Scott StuartApr 29, 2015 4:44 PM EDT
MERGERS AND ACQUISITIONSTeva Won't Let Regulators, Poison Pill Stop Its Quest for MylanBy Scott StuartApr 22, 2015 9:46 AM EDT
MERGERS AND ACQUISITIONSAbbVie Refiles for Antitrust Review of Pharmacyclics DealBy Scott StuartApr 20, 2015 7:12 PM EDT
MERGERS AND ACQUISITIONSHudson City Lending Probe Not Likely a Deal KillerBy Scott StuartApr 16, 2015 9:08 PM EDT
MERGERS AND ACQUISITIONSHudson City lending probe not likely a deal killerBy Scott StuartApr 16, 2015 4:10 PM EDT
MERGERS AND ACQUISITIONSFTC Staff Nears Store Divestiture Tally for Family Dollar DealBy Scott StuartApr 8, 2015 5:21 PM EDT
MERGERS AND ACQUISITIONSTokyo Electron Arbitrage Spread Wide on Possible S. Korea DelayBy Scott StuartDec 2, 2014 9:11 AM EST
MERGERS AND ACQUISITIONSPershing Square is Handed a Partial Win in Allergan CaseBy Scott StuartNov 5, 2014 9:14 AM EST
MERGERS AND ACQUISITIONSApproval Progress Fails to Eliminate Bally Concerns in $5.1 Billion DealBy Scott StuartOct 21, 2014 9:18 AM EDT
MERGERS AND ACQUISITIONSRiverbed Technology Will Explore Strategic AlternativesBy Scott StuartOct 10, 2014 10:24 AM EDT
MERGERS AND ACQUISITIONSAlbemarle Stock Price Slide Creates Doubt for Rockwood DealBy Scott StuartOct 2, 2014 10:14 AM EDT
MERGERS AND ACQUISITIONSAuxilium Pharmaceuticals' Slow Response to Endo Troubles InvestorsBy Scott StuartSep 18, 2014 9:52 AM EDT
MERGERS AND ACQUISITIONSTreasury Secretary's Upcoming Inversion Talk to Widen SpreadsBy Scott StuartSep 5, 2014 9:21 AM EDT
MERGERS AND ACQUISITIONSDollar General Spoiler Bid Clouded by Antitrust IssuesBy Scott StuartAug 19, 2014 11:44 AM EDT
MERGERS AND ACQUISITIONSAllergan Reiterates Plan to Preempt Valeant OfferBy Scott StuartJul 22, 2014 9:37 AM EDT
MERGERS AND ACQUISITIONSHittite Microwave Details Sale Process Before Analog DealBy Scott StuartJun 24, 2014 10:21 AM EDT
MERGERS AND ACQUISITIONSReservations in OpenTable Trading for Higher OfferBy Scott StuartJun 18, 2014 9:39 AM EDT
MERGERS AND ACQUISITIONSValeant Raises Hostile Offer for AllerganBy Scott StuartMay 28, 2014 11:45 AM EDT
MERGERS AND ACQUISITIONSSkepticism Abounds That Hillshire-Pinnacle Deal Will WrapBy Scott StuartMay 16, 2014 10:07 AM EDT
MERGERS AND ACQUISITIONSInternational Regulators are Likely to Clear Applied Materials-Tokyo Electron DealBy Scott StuartMay 15, 2014 9:44 AM EDT
